CA2732498A1 - Procedes pour le ciblage de genes - Google Patents

Procedes pour le ciblage de genes Download PDF

Info

Publication number: CA2732498A1
Authority: CA; Canada
Prior art keywords: tag; cells; marker; tagged; gene
Prior art date: 2008-07-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2732498A

Other languages

English (en)

Inventor

Michael Strathmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-30

Filing date

2008-07-30

Publication date

2010-02-04

2008-07-30 Application filed by Individual filed Critical Individual

2010-02-04 Publication of CA2732498A1 publication Critical patent/CA2732498A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 39
238000010363 gene targeting Methods 0.000 title abstract description 7
239000003550 marker Substances 0.000 claims description 72
238000003780 insertion Methods 0.000 claims description 30
230000037431 insertion Effects 0.000 claims description 29
230000009368 gene silencing by RNA Effects 0.000 claims description 25
108091030071 RNAI Proteins 0.000 claims description 17
108020004459 Small interfering RNA Proteins 0.000 claims description 13
108091034117 Oligonucleotide Proteins 0.000 claims description 7
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 5
108091027967 Small hairpin RNA Proteins 0.000 claims description 4
230000000694 effects Effects 0.000 claims description 4
239000002679 microRNA Substances 0.000 claims description 4
239000004055 small Interfering RNA Substances 0.000 claims description 4
102000053642 Catalytic RNA Human genes 0.000 claims description 3
108090000994 Catalytic RNA Proteins 0.000 claims description 3
108091023040 Transcription factor Proteins 0.000 claims description 3
102000040945 Transcription factor Human genes 0.000 claims description 3
108091092562 ribozyme Proteins 0.000 claims description 3
150000001875 compounds Chemical class 0.000 claims description 2
230000000692 anti-sense effect Effects 0.000 claims 1
108091070501 miRNA Proteins 0.000 claims 1
230000008685 targeting Effects 0.000 abstract description 8
210000004027 cell Anatomy 0.000 description 109
108090000623 proteins and genes Proteins 0.000 description 58
239000013598 vector Substances 0.000 description 25
238000002744 homologous recombination Methods 0.000 description 17
230000006801 homologous recombination Effects 0.000 description 17
238000012163 sequencing technique Methods 0.000 description 13
230000010354 integration Effects 0.000 description 11
239000000047 product Substances 0.000 description 11
108020004414 DNA Proteins 0.000 description 9
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 8
239000002299 complementary DNA Substances 0.000 description 8
108020004707 nucleic acids Proteins 0.000 description 8
102000039446 nucleic acids Human genes 0.000 description 8
150000007523 nucleic acids Chemical class 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
238000010188 recombinant method Methods 0.000 description 6
230000006798 recombination Effects 0.000 description 6
238000005215 recombination Methods 0.000 description 6
230000001177 retroviral effect Effects 0.000 description 6
238000001890 transfection Methods 0.000 description 6
230000004927 fusion Effects 0.000 description 5
230000014509 gene expression Effects 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
101001060278 Xenopus laevis Fibroblast growth factor 3 Proteins 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000002245 particle Substances 0.000 description 4
238000010187 selection method Methods 0.000 description 4
108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
108700011259 MicroRNAs Proteins 0.000 description 3
241000700605 Viruses Species 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
238000007429 general method Methods 0.000 description 3
239000005090 green fluorescent protein Substances 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
RJOXFJDOUQJOMQ-UHFFFAOYSA-N 6-sulfanylidene-3,7-dihydropurin-2-one Chemical compound S=C1NC(=O)NC2=C1NC=N2 RJOXFJDOUQJOMQ-UHFFFAOYSA-N 0.000 description 2
108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108700024394 Exon Proteins 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
108700008625 Reporter Genes Proteins 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000003321 amplification Effects 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
239000000074 antisense oligonucleotide Substances 0.000 description 2
238000012230 antisense oligonucleotides Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000012737 fresh medium Substances 0.000 description 2
101150106093 gpt gene Proteins 0.000 description 2
230000009610 hypersensitivity Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
230000035772 mutation Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
101710160107 Outer membrane protein A Proteins 0.000 description 1
108020005067 RNA Splice Sites Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
238000002493 microarray Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
238000004091 panning Methods 0.000 description 1
238000011176 pooling Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000000135 prohibitive effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
239000012096 transfection reagent Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
239000013603 viral vector Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Crystallography & Structural Chemistry (AREA)
Bioinformatics & Computational Biology (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA2732498A 2008-07-30 2008-07-30 Procedes pour le ciblage de genes Abandoned CA2732498A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/071667 WO2010014090A1 (fr)	2008-07-30	2008-07-30	Procédés pour le ciblage de gènes

Publications (1)

Publication Number	Publication Date
CA2732498A1 true CA2732498A1 (fr)	2010-02-04

Family

ID=41610616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2732498A Abandoned CA2732498A1 (fr)	2008-07-30	2008-07-30	Procedes pour le ciblage de genes

Country Status (3)

Country	Link
EP (1)	EP2318527A4 (fr)
CA (1)	CA2732498A1 (fr)
WO (1)	WO2010014090A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6689610B1 (en) *	1989-08-22	2004-02-10	University Of Utah Research Foundation	Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
CA2323834C (fr) *	1998-03-27	2009-01-27	Lexicon Genetics Incorporated	Vecteurs pour mutagenese de genes et decouverte de genes
US6480791B1 (en) *	1998-10-28	2002-11-12	Michael P. Strathmann	Parallel methods for genomic analysis
WO2001002555A1 (fr) *	1999-07-06	2001-01-11	Institut Pasteur	Methode de production et d'identification de micro-organismes attenues, compositions faisant intervenir les sequences responsables de cette attenuation et preparation contenant les micro-organismes attenues
WO2002079467A2 (fr) *	2001-03-29	2002-10-10	Københavns Universitet	Selection de souche bacterienne sans antibiotique a l'aide de molecules antisens
EP1607482A1 (fr) *	2004-06-16	2005-12-21	Gbf-Gesellschaft Für Biotechnologische Forschung Mbh	Procédé de sélection des cellules eucaryotiques transformées à base d'ARNi
US20070224613A1 (en) *	2006-02-18	2007-09-27	Strathmann Michael P	Massively Multiplexed Sequencing
DE102006016365B4 (de) *	2006-04-05	2015-08-13	Qiagen Gmbh	RNA-Interferenz Tags
US20080188001A1 (en) *	2007-02-06	2008-08-07	Michael Paul Strathmann	Methods For Gene Targeting
CA2678055C (fr) *	2007-04-10	2016-02-16	Qiagen Gmbh	Etiquettes d'interference arn
EP2218781A1 (fr) *	2009-02-11	2010-08-18	Qiagen GmbH	Système de sélection à base d'ARNi

2008
- 2008-07-30 EP EP08782548A patent/EP2318527A4/fr not_active Withdrawn
- 2008-07-30 CA CA2732498A patent/CA2732498A1/fr not_active Abandoned
- 2008-07-30 WO PCT/US2008/071667 patent/WO2010014090A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2010014090A1 (fr)	2010-02-04
EP2318527A1 (fr)	2011-05-11
EP2318527A4 (fr)	2012-07-04

Publication	Publication Date	Title
JP4747245B2 (ja)	2011-08-17	ＲＮＡｉライブラリーの酵素的構築方法
Wiley	2013	RNA Interference (RNAi)
AU2015308910B2 (en)	2017-12-07	Methods for increasing Cas9-mediated engineering efficiency
JP2019162140A (ja)	2019-09-26	Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法
WO2017161068A1 (fr)	2017-09-21	Protéines cas mutantes
CN105255937A (zh)	2016-01-20	一种真核细胞III型启动子表达CRISPR sgRNA的方法及其应用
WO2005056750A2 (fr)	2005-06-23	Inversion-duplication d'acides nucleiques et bibliotheques preparees de cette maniere
US20210147841A1 (en)	2021-05-20	Compositions and methods for modifying regulatory t cells
CN100570022C (zh)	2009-12-16	PCR高通量构建siRNA全位点分子库制备方法
CN112384620B (zh)	2023-06-30	用于筛选和鉴定功能性lncRNA的方法
US7524653B2 (en)	2009-04-28	Small interfering RNA libraries and methods of synthesis and use
WO2020223539A1 (fr)	2020-11-05	Procédés et compositions permettant de marquer des banques d'acide nucléique et des populations cellulaires avec un code-barres
US20080188001A1 (en)	2008-08-07	Methods For Gene Targeting
WO2022236147A1 (fr)	2022-11-10	Nucléases modifiées
CA3068281A1 (fr)	2018-12-27	Compositions et procedes d'amelioration de l'efficacite d'une immunotherapie basee sur des lymphocytes t
CA2732498A1 (fr)	2010-02-04	Procedes pour le ciblage de genes
CN102203281B (zh)	2013-04-17	复制条码筛选检测
US20170298351A1 (en)	2017-10-19	Method For Screening Interfering Molecules
EP3960862A1 (fr)	2022-03-02	Capteurs d'aptamère d'arn
von Niessen	2016	Optimization of RNA Cancer Vaccines Using 3'UTR Sequences Selected for Stabilization of RNA
WO2025101943A1 (fr)	2025-05-15	Synthèse d'adn guidée par acide nucléique
US9777277B2 (en)	2017-10-03	Organic small hairpin RNAs
Erard	2018	Optimization of molecular tools for high-throughput genetic screening
Namiki et al.	2004	Enzymatic production of RNAi libraries from cDNAs.
HK40045732B (en)	2023-09-15	Method for screening and identifying functional lncrnas

Legal Events

Date	Code	Title	Description
2014-09-24	FZDE	Discontinued	Effective date: 20140730